|1.||Harrison, P R: 2 articles (10/2001 - 01/2001)|
|2.||Ghose, A: 2 articles (10/2001 - 01/2001)|
|3.||Fleming, J: 2 articles (10/2001 - 01/2001)|
|4.||Okamoto, Yoshinori: 1 article (06/2015)|
|5.||Kojima, Nakao: 1 article (06/2015)|
|6.||Ando, Motozumi: 1 article (06/2015)|
|7.||Tobe, Takao: 1 article (06/2015)|
|8.||Ueda, Koji: 1 article (06/2015)|
|9.||Maharaj, L: 1 article (05/2006)|
|10.||Last, K: 1 article (05/2006)|
06/01/2015 - "Thiol-mediated multiple mechanisms centered on selenodiglutathione determine selenium cytotoxicity against MCF-7 cancer cells."
07/01/1986 - "Selenodiglutathione was the most effective form of selenium examined that inhibited tumor cell growth. "
10/15/2001 - "Two SE compounds were tested: selenodiglutathione (SDG), the primary metabolite of selenite and the most commonly used cancer-protective SE compound in animal models, and the synthetic SE compound, 1,4-phenylenebis(methylene)selenocyanate (p-XSC), one of the most potent chemopreventive pharmacological SE compounds. "
01/01/2001 - "Our recent work has shown that primary cultures of oral carcinoma biopsies are significantly more sensitive than normal oral mucosa cultures to induction of apoptosis by a natural selenium metabolite [selenodiglutathione (SDG)], and this is associated with induction of Fas ligand, a well-known mediator of apoptosis in other contexts, and activation of so-called stress kinase signaling pathways, particularly the Jun NH2-terminal kinase (JNK). "
|5.||Body Weight (Weight, Body)
|2.||Sodium Selenite (Selenite)
|3.||Fas Ligand Protein (Fas Ligand)